25 XP   0   0   10

PAVmed Inc
Buy, Hold or Sell?

Let's analyse Pavmed together

PenkeI guess you are interested in PAVmed Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PAVmed Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about PAVmed Inc

I send you an email if I find something interesting about PAVmed Inc.

Quick analysis of Pavmed (30 sec.)










What can you expect buying and holding a share of Pavmed? (30 sec.)

How much money do you get?

How much money do you get?
$1.23
When do you have the money?
1 year
How often do you get paid?
35.1%

What is your share worth?

Current worth
$-2.92
Expected worth in 1 year
$-7.20
How sure are you?
37.8%

+ What do you gain per year?

Total Gains per Share
$-3.05
Return On Investment
-163.9%

For what price can you sell your share?

Current Price per Share
$1.86
Expected price per share
$1.6 - $4.44
How sure are you?
50%

1. Valuation of Pavmed (5 min.)




Live pricePrice per Share (EOD)

$1.86

Intrinsic Value Per Share

$-86.35 - $-102.60

Total Value Per Share

$-89.27 - $-105.53

2. Growth of Pavmed (5 min.)




Is Pavmed growing?

Current yearPrevious yearGrowGrow %
How rich?-$24m$40m-$47.5m-636.7%

How much money is Pavmed making?

Current yearPrevious yearGrowGrow %
Making money$1b-$22.3m$1b102.2%
Net Profit Margin231,600.6%-14,611.1%--

How much money comes from the company's main activities?

3. Financial Health of Pavmed (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#332 / 339

Most Revenue
#281 / 339

Most Profit
#4 / 339

What can you expect buying and holding a share of Pavmed? (5 min.)

Welcome investor! Pavmed's management wants to use your money to grow the business. In return you get a share of Pavmed.

What can you expect buying and holding a share of Pavmed?

First you should know what it really means to hold a share of Pavmed. And how you can make/lose money.

Speculation

The Price per Share of Pavmed is $1.86. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pavmed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pavmed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-2.92. Based on the TTM, the Book Value Change Per Share is $-1.07 per quarter. Based on the YOY, the Book Value Change Per Share is $0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.31 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pavmed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.71-91.8%-1.99-107.0%-0.84-45.2%-0.67-36.0%-0.43-23.3%
Usd Book Value Change Per Share-0.96-51.5%-1.07-57.5%0.115.9%-0.14-7.6%-0.08-4.2%
Usd Dividend Per Share0.000.0%0.3116.6%1.3572.4%111.996,021.0%60.543,254.6%
Usd Total Gains Per Share-0.96-51.5%-0.76-41.0%1.4678.3%111.856,013.4%60.463,250.4%
Usd Price Per Share4.12-1.30-0.90-2.15-2.32-
Price to Earnings Ratio-0.60--0.18--0.76--3.08--2.51-
Price-to-Total Gains Ratio-4.30--1.11--1.61--20.81--25.44-
Price to Book Ratio-1.41--1.31-1.58--12.28--8.17-
Price-to-Total Gains Ratio-4.30--1.11--1.61--20.81--25.44-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.86
Number of shares537
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.31111.99
Usd Book Value Change Per Share-1.07-0.14
Usd Total Gains Per Share-0.76111.85
Gains per Quarter (537 shares)-409.2660,062.91
Gains per Year (537 shares)-1,637.05240,251.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1662-2299-1647240556-304240242
21324-4598-3284481112-608480494
31986-6897-4921721667-912720746
42648-9196-6558962223-1217960998
53310-11495-81951202779-15211201250
63972-13794-98321443335-18251441502
74634-16094-114691683891-21291681754
85296-18393-131061924446-24331922006
95958-20692-147432165002-27372162258
106620-22991-163802405558-30422402510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.036.00.02.7%1.036.00.02.7%
Book Value Change Per Share0.04.00.00.0%4.08.00.033.3%6.014.00.030.0%12.024.01.032.4%12.024.01.032.4%
Dividend per Share1.00.03.025.0%3.00.09.025.0%6.00.014.030.0%13.00.024.035.1%13.00.024.035.1%
Total Gains per Share1.03.00.025.0%5.07.00.041.7%8.012.00.040.0%14.022.01.037.8%14.022.01.037.8%

Fundamentals of Pavmed

About PAVmed Inc

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2024-04-12 14:35:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of PAVmed Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pavmed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pavmed to the Medical Devices industry mean.
  • A Net Profit Margin of -1,338.0% means that $-13.38 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PAVmed Inc:

  • The MRQ is -1,338.0%. The company is making a huge loss. -2
  • The TTM is 231,600.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-1,338.0%TTM231,600.6%-232,938.6%
TTM231,600.6%YOY-14,611.1%+246,211.6%
TTM231,600.6%5Y42,805.3%+188,795.3%
5Y42,805.3%10Y23,138.0%+19,667.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,338.0%-11.2%-1,326.8%
TTM231,600.6%-19.6%+231,620.2%
YOY-14,611.1%-14.4%-14,596.7%
5Y42,805.3%-21.3%+42,826.6%
10Y23,138.0%-24.8%+23,162.8%
1.1.2. Return on Assets

Shows how efficient Pavmed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pavmed to the Medical Devices industry mean.
  • -42.4% Return on Assets means that Pavmed generated $-0.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PAVmed Inc:

  • The MRQ is -42.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 1,575.3%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ-42.4%TTM1,575.3%-1,617.7%
TTM1,575.3%YOY-31.2%+1,606.5%
TTM1,575.3%5Y277.6%+1,297.7%
5Y277.6%10Y101.4%+176.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.4%-4.0%-38.4%
TTM1,575.3%-4.5%+1,579.8%
YOY-31.2%-4.8%-26.4%
5Y277.6%-4.0%+281.6%
10Y101.4%-4.9%+106.3%
1.1.3. Return on Equity

Shows how efficient Pavmed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pavmed to the Medical Devices industry mean.
  • 0.0% Return on Equity means Pavmed generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PAVmed Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-109.0%+109.0%
TTM-5Y-50.3%+50.3%
5Y-50.3%10Y-79.9%+29.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.9%+3.9%
TTM--5.6%+5.6%
YOY-109.0%-5.9%-103.1%
5Y-50.3%-6.1%-44.2%
10Y-79.9%-7.0%-72.9%

1.2. Operating Efficiency of PAVmed Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pavmed is operating .

  • Measures how much profit Pavmed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pavmed to the Medical Devices industry mean.
  • An Operating Margin of -1,561.8% means the company generated $-15.62  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PAVmed Inc:

  • The MRQ is -1,561.8%. The company is operating very inefficient. -2
  • The TTM is -4,557.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,561.8%TTM-4,557.1%+2,995.3%
TTM-4,557.1%YOY-14,778.3%+10,221.2%
TTM-4,557.1%5Y-4,536.8%-20.4%
5Y-4,536.8%10Y-2,452.3%-2,084.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,561.8%-24.1%-1,537.7%
TTM-4,557.1%-16.9%-4,540.2%
YOY-14,778.3%-13.4%-14,764.9%
5Y-4,536.8%-19.2%-4,517.6%
10Y-2,452.3%-24.0%-2,428.3%
1.2.2. Operating Ratio

Measures how efficient Pavmed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 16.62 means that the operating costs are $16.62 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of PAVmed Inc:

  • The MRQ is 16.618. The company is inefficient in keeping operating costs low. -1
  • The TTM is 46.073. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ16.618TTM46.073-29.455
TTM46.073YOY148.533-102.460
TTM46.0735Y45.792+0.281
5Y45.79210Y24.752+21.039
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ16.6181.431+15.187
TTM46.0731.426+44.647
YOY148.5331.503+147.030
5Y45.7921.440+44.352
10Y24.7521.371+23.381

1.3. Liquidity of PAVmed Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pavmed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.45 means the company has $0.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of PAVmed Inc:

  • The MRQ is 0.452. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.741. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.452TTM0.741-0.288
TTM0.741YOY3.825-3.085
TTM0.7415Y3.248-2.507
5Y3.24810Y3.679-0.431
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4522.754-2.302
TTM0.7412.763-2.022
YOY3.8253.488+0.337
5Y3.2483.617-0.369
10Y3.6793.514+0.165
1.3.2. Quick Ratio

Measures if Pavmed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pavmed to the Medical Devices industry mean.
  • A Quick Ratio of 0.36 means the company can pay off $0.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PAVmed Inc:

  • The MRQ is 0.364. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.678. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.364TTM0.678-0.314
TTM0.678YOY3.625-2.947
TTM0.6785Y2.545-1.868
5Y2.54510Y2.715-0.170
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3641.532-1.168
TTM0.6781.656-0.978
YOY3.6252.139+1.486
5Y2.5452.301+0.244
10Y2.7152.255+0.460

1.4. Solvency of PAVmed Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pavmed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pavmed to Medical Devices industry mean.
  • A Debt to Asset Ratio of 1.73 means that Pavmed assets are financed with 172.5% credit (debt) and the remaining percentage (100% - 172.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PAVmed Inc:

  • The MRQ is 1.725. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.238. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.725TTM1.238+0.487
TTM1.238YOY0.497+0.741
TTM1.2385Y1.032+0.206
5Y1.03210Y1.648-0.616
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7250.389+1.336
TTM1.2380.386+0.852
YOY0.4970.338+0.159
5Y1.0320.442+0.590
10Y1.6480.460+1.188
1.4.2. Debt to Equity Ratio

Measures if Pavmed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pavmed to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PAVmed Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.724-1.724
TTM-5Y0.906-0.906
5Y0.90610Y1.020-0.115
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.559-0.559
TTM-0.560-0.560
YOY1.7240.478+1.246
5Y0.9060.624+0.282
10Y1.0200.674+0.346

2. Market Valuation of PAVmed Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pavmed generates.

  • Above 15 is considered overpriced but always compare Pavmed to the Medical Devices industry mean.
  • A PE ratio of -0.60 means the investor is paying $-0.60 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PAVmed Inc:

  • The EOD is -0.272. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.603. Based on the earnings, the company is expensive. -2
  • The TTM is -0.184. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.272MRQ-0.603+0.331
MRQ-0.603TTM-0.184-0.419
TTM-0.184YOY-0.764+0.581
TTM-0.1845Y-3.079+2.895
5Y-3.07910Y-2.511-0.568
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.272-0.997+0.725
MRQ-0.603-1.578+0.975
TTM-0.184-2.041+1.857
YOY-0.764-2.761+1.997
5Y-3.079-2.064-1.015
10Y-2.511-1.463-1.048
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PAVmed Inc:

  • The EOD is -0.317. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.702. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.216. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.317MRQ-0.702+0.385
MRQ-0.702TTM-0.216-0.486
TTM-0.216YOY-0.835+0.619
TTM-0.2165Y-4.192+3.975
5Y-4.19210Y-5.214+1.022
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.317-0.935+0.618
MRQ-0.702-1.489+0.787
TTM-0.216-2.994+2.778
YOY-0.835-6.238+5.403
5Y-4.192-4.771+0.579
10Y-5.214-4.736-0.478
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pavmed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -1.41 means the investor is paying $-1.41 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of PAVmed Inc:

  • The EOD is -0.636. Based on the equity, the company is expensive. -2
  • The MRQ is -1.409. Based on the equity, the company is expensive. -2
  • The TTM is -1.309. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.636MRQ-1.409+0.773
MRQ-1.409TTM-1.309-0.100
TTM-1.309YOY1.577-2.886
TTM-1.3095Y-12.283+10.974
5Y-12.28310Y-8.169-4.114
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.6361.890-2.526
MRQ-1.4092.379-3.788
TTM-1.3092.458-3.767
YOY1.5773.214-1.637
5Y-12.2833.833-16.116
10Y-8.1694.173-12.342
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of PAVmed Inc.

3.1. Institutions holding PAVmed Inc

Institutions are holding 12.407% of the shares of PAVmed Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Ayrton Capital LLC1.85844.482822442351794635399.1626
2023-12-31Vanguard Group Inc3.758803026063026060
2023-12-31First Manhattan Co. LLC2.48430.0029200000133340200.03
2023-12-31BlackRock Inc0.9306074922110.0147
2023-12-31Geode Capital Management, LLC0.6841055078110.02
2023-12-31Susquehanna International Group, LLP0.2802022561225610
2023-12-31Valeo Financial Advisors, LLC0.26250.003521129-354-1.6478
2023-12-31State Street Corporation0.2606020981222411.8569
2023-12-31Northern Trust Corp0.1609012957370640.0605
2023-12-31Wells Fargo & Co0.1418011418-8686-43.2053
2023-12-31XML Financial, LLC0.12840.00451033420.0194
2023-12-31UBS Group AG0.07470601759377421.25
2023-12-31CWM, LLC duplicate0.0580.0001467210.0214
2023-12-31Tower Research Capital LLC0.04690.000237723259.4285
2023-12-31Morgan Stanley - Brokerage Accounts0.032102584-1165-31.075
2023-12-31Glassman Wealth Services0.02880.0014231910.0431
2023-09-30Cutler Group LP0.001101318-600-31.2826
2023-12-31Hanson Mcclain Inc0.01270102430.2938
2023-12-31SIMPLEX TRADING, LLC0.01230991-231-18.9034
2023-12-31Advisor Group Holdings, Inc.0.00230182-113-38.3051
Total 11.21954.49542999100+2254214+75.2%

3.2. Funds holding PAVmed Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.332021389600
2023-09-30BlackRock Extended Mkt Composite0.12110.000416666500
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.86880.00027968900
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.03750.000151627-2444301-97.9316
2024-02-29Fidelity Extended Market Index0.42620.000339097-189-0.4811
2024-03-31BlackRock Extended Equity Market K0.10570.0001969730.0309
2024-02-29Fidelity Series Total Market Index0.10140930400
2023-12-31Northern Trust Extended Eq Market Idx0.08720.00067996370486.3001
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08720.00067996370486.3001
2024-02-29Fidelity Total Market Index0.08560785000
2024-02-29Schwab Total Stock Market Index0.05780.0001530100
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.04810.0003440910.0227
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03860.0003354170.1981
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.03750344200
2024-02-29Fidelity Nasdaq Composite Index0.0330.0001302600
2024-03-31State St US Extended Mkt Indx NL Cl C0.03130.0003286700
2023-12-31SSgA U.S. Extended Market Index Class I0.03130.0004286710.0349
2024-02-29Spartan Total Market Index Pool E0.02560235200
2024-03-31BlackRock U.S. Equity Market F0.020601886180.9636
2024-02-29Vanguard U.S. Eq Idx £ Acc0.01970180500
Total 4.59620.0038625313-2437052-389.7%

3.3. Insider Transactions

Insiders are holding 7.233% of the shares of PAVmed Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-12-07Michael J GlennonBUY66669.3
2022-12-05Michael J GlennonBUY413310.35
2021-10-18Pavmed Inc.BUY38095210

4. Summary

4.1. Key Performance Indicators

The key performance indicators of PAVmed Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.957-1.070+12%0.110-973%-0.142-85%-0.079-92%
Book Value Per Share---2.923-0.913-69%0.794-468%0.046-6511%0.017-17386%
Current Ratio--0.4520.741-39%3.825-88%3.248-86%3.679-88%
Debt To Asset Ratio--1.7251.238+39%0.497+247%1.032+67%1.648+5%
Debt To Equity Ratio----0%1.724-100%0.906-100%1.020-100%
Dividend Per Share---0.308-100%1.346-100%111.991-100%60.536-100%
Eps---1.708-1.991+17%-0.840-51%-0.669-61%-0.433-75%
Free Cash Flow Per Share---1.467-1.616+10%-0.711-52%-0.538-63%-0.327-78%
Free Cash Flow To Equity Per Share---0.824-0.651-21%-0.407-51%-0.160-81%-0.046-94%
Gross Profit Margin--1.3341.207+11%1.293+3%1.107+20%1.058+26%
Intrinsic Value_10Y_max---102.603--------
Intrinsic Value_10Y_min---86.348--------
Intrinsic Value_1Y_max---4.293--------
Intrinsic Value_1Y_min---4.213--------
Intrinsic Value_3Y_max---17.463--------
Intrinsic Value_3Y_min---16.579--------
Intrinsic Value_5Y_max---36.135--------
Intrinsic Value_5Y_min---33.147--------
Market Cap14974227.600-126%33851530.92010628309.004+219%66164210.844-49%128230531.408-74%85850704.641-61%
Net Profit Margin---13.3802316.006-101%-146.111+992%428.053-103%231.380-106%
Operating Margin---15.618-45.571+192%-147.783+846%-45.368+190%-24.523+57%
Operating Ratio--16.61846.073-64%148.533-89%45.792-64%24.752-33%
Pb Ratio-0.636+55%-1.409-1.309-7%1.577-189%-12.283+771%-8.169+480%
Pe Ratio-0.272+55%-0.603-0.184-70%-0.764+27%-3.079+411%-2.511+317%
Price Per Share1.860-122%4.1201.299+217%0.899+358%2.151+92%2.324+77%
Price To Free Cash Flow Ratio-0.317+55%-0.702-0.216-69%-0.835+19%-4.192+497%-5.214+643%
Price To Total Gains Ratio-1.943+55%-4.305-1.109-74%-1.611-63%-20.809+383%-25.444+491%
Quick Ratio--0.3640.678-46%3.625-90%2.545-86%2.715-87%
Return On Assets---0.42415.753-103%-0.312-26%2.776-115%1.014-142%
Return On Equity----0%-1.0900%-0.5030%-0.7990%
Total Gains Per Share---0.957-0.762-20%1.455-166%111.849-101%60.457-102%
Usd Book Value---24018000.000-7468000.000-69%40078000.000-160%14554739.350-265%7818125.432-407%
Usd Book Value Change Per Share---0.957-1.070+12%0.110-973%-0.142-85%-0.079-92%
Usd Book Value Per Share---2.923-0.913-69%0.794-468%0.046-6511%0.017-17386%
Usd Dividend Per Share---0.308-100%1.346-100%111.991-100%60.536-100%
Usd Eps---1.708-1.991+17%-0.840-51%-0.669-61%-0.433-75%
Usd Free Cash Flow---12057000.000-13069500.000+8%-19435500.000+61%-10344147.250-14%-6167176.757-49%
Usd Free Cash Flow Per Share---1.467-1.616+10%-0.711-52%-0.538-63%-0.327-78%
Usd Free Cash Flow To Equity Per Share---0.824-0.651-21%-0.407-51%-0.160-81%-0.046-94%
Usd Market Cap14974227.600-126%33851530.92010628309.004+219%66164210.844-49%128230531.408-74%85850704.641-61%
Usd Price Per Share1.860-122%4.1201.299+217%0.899+358%2.151+92%2.324+77%
Usd Profit---14036000.0001035116250.000-101%-22349250.000+59%197746099.950-107%105930375.378-113%
Usd Revenue--1049000.000613000.000+71%122000.000+760%172000.000+510%92972.973+1028%
Usd Total Gains Per Share---0.957-0.762-20%1.455-166%111.849-101%60.457-102%
 EOD+2 -6MRQTTM+17 -17YOY+10 -255Y+7 -2810Y+7 -28

4.2. Fundamental Score

Let's check the fundamental score of PAVmed Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.272
Price to Book Ratio (EOD)Between0-1-0.636
Net Profit Margin (MRQ)Greater than0-13.380
Operating Margin (MRQ)Greater than0-15.618
Quick Ratio (MRQ)Greater than10.364
Current Ratio (MRQ)Greater than10.452
Debt to Asset Ratio (MRQ)Less than11.725
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.424
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of PAVmed Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.568
Ma 20Greater thanMa 502.099
Ma 50Greater thanMa 1002.182
Ma 100Greater thanMa 2002.776
OpenGreater thanClose1.960
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Interest Income  -223161-62-3-6530-3511378



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets33,119
Total Liabilities57,137
Total Stockholder Equity-53,831
 As reported
Total Liabilities 57,137
Total Stockholder Equity+ -53,831
Total Assets = 33,119

Assets

Total Assets33,119
Total Current Assets24,498
Long-term Assets8,621
Total Current Assets
Cash And Cash Equivalents 19,639
Net Receivables 61
Inventory 1,017
Other Current Assets 3,781
Total Current Assets  (as reported)24,498
Total Current Assets  (calculated)24,498
+/- 0
Long-term Assets
Property Plant Equipment 6,050
Intangible Assets 1,424
Long-term Assets Other 1,147
Long-term Assets  (as reported)8,621
Long-term Assets  (calculated)8,621
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities54,177
Long-term Liabilities2,960
Total Stockholder Equity-53,831
Total Current Liabilities
Short-term Debt 45,765
Short Long Term Debt 44,200
Accounts payable 1,786
Other Current Liabilities 6,626
Total Current Liabilities  (as reported)54,177
Total Current Liabilities  (calculated)98,377
+/- 44,200
Long-term Liabilities
Capital Lease Obligations 4,525
Long-term Liabilities  (as reported)2,960
Long-term Liabilities  (calculated)4,525
+/- 1,565
Total Stockholder Equity
Common Stock9
Retained Earnings -294,433
Other Stockholders Equity 237,609
Total Stockholder Equity (as reported)-53,831
Total Stockholder Equity (calculated)-56,815
+/- 2,984
Other
Capital Stock3,002
Cash and Short Term Investments 19,639
Common Stock Shares Outstanding 8,216
Liabilities and Stockholders Equity 33,119
Net Debt 29,086
Net Invested Capital -12,624
Net Working Capital -29,679
Property Plant and Equipment Gross 7,769
Short Long Term Debt Total 48,725



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
> Total Assets 
842
791
573
1,810
1,214
1,214
3,153
1,986
870
1,094
226
3,233
1,640
3,759
11,237
9,398
8,496
8,496
7,060
4,406
7,240
7,240
8,882
10,504
19,778
51,369
47,371
42,985
86,976
86,976
82,454
72,465
53,980
65,286
53,683
42,020
33,119
33,11942,02053,68365,28653,98072,46582,45486,97686,97642,98547,37151,36919,77810,5048,8827,2407,2404,4067,0608,4968,4969,39811,2373,7591,6403,2332261,0948701,9863,1531,2141,2141,810573791842
   > Total Current Assets 
842
791
526
1,415
776
776
3,139
1,966
741
1,072
207
3,215
1,623
3,745
11,225
9,362
8,460
8,460
7,006
4,355
6,548
6,548
8,154
9,780
18,941
50,508
46,336
41,732
82,637
82,637
70,815
61,979
43,926
53,841
43,127
32,461
24,498
24,49832,46143,12753,84143,92661,97970,81582,63782,63741,73246,33650,50818,9419,7808,1546,5486,5484,3557,0068,4608,4609,36211,2253,7451,6233,2152071,0727411,9663,1397767761,415526791842
       Cash And Cash Equivalents 
839
729
522
1,415
767
767
3,023
1,789
586
906
82
3,111
1,535
3,631
11,138
9,242
8,222
8,222
6,908
4,098
6,219
6,219
7,080
8,293
17,256
48,546
43,210
37,341
77,258
77,258
65,153
56,785
39,744
49,280
37,163
26,408
19,639
19,63926,40837,16349,28039,74456,78565,15377,25877,25837,34143,21048,54617,2568,2937,0806,2196,2194,0986,9088,2228,2229,24211,1383,6311,5353,111829065861,7893,0237677671,415522729839
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,317
3,980
3,005
3,530
4,314
0
0
004,3143,5303,0053,9803,317000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
25
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
200
0
31
17
27
41
36
61
61364127173102002002000000000000000000000002500000
       Other Current Assets 
3
9
4
0
9
9
116
178
155
167
125
103
88
114
87
120
238
238
98
257
294
328
375
1,487
855
1,962
3,126
4,141
2,084
526
355
149
3,904
4,534,000
5,923,000
6,017,000
3,781
3,7816,017,0005,923,0004,534,0003,9041493555262,0844,1413,1261,9628551,487375328294257982382381208711488103125167155178116990493
   > Long-term Assets 
0
0
47
395
0
438
14
19
129
22
20
18
16
14
13
37
36
36
55
51
693
693
728
724
837
861
1,035
1,253
4,339
4,339
11,639
10,486
10,054
11,445
10,556
9,559
8,621
8,6219,55910,55611,44510,05410,48611,6394,3394,3391,2531,0358618377247286936935155363637131416182022129191443803954700
       Property Plant Equipment 
0
0
0
0
0
12
14
19
18
22
20
18
16
14
13
37
36
36
55
51
693
691
0
0
0
0
0
451
1,585
1,585
5,458
5,453
5,488
7,426
7,042
6,483
6,050
6,0506,4837,0427,4265,4885,4535,4581,5851,5854510000069169351553636371314161820221819141200000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47
0
2,029,000
4,456,000
3,950
3,445
2,940
2,435
1,929
1,424
1,4241,9292,4352,9403,4453,9504,456,0002,029,000047000000000000000000000000000
       Other Assets 
0
0
0
395
438
442
0
0
111
0
0
0
0
0
0
0
0
0
0
0
693
691
728
724
837
861
965
755
725
695
1,725
1,083
1,121
1,079
0
0
0
0001,0791,1211,0831,7256957257559658618377247286916930000000000011100442438395000
> Total Liabilities 
47
42
85
239
580
580
403
842
1,189
5,409
5,276
9,146
4,488
3,511
4,715
5,835
10,973
10,973
8,940
6,813
11,879
11,879
21,687
25,265
20,251
3,329
5,331
7,751
7,558
7,558
41,050
43,909
43,046
54,482
54,513
57,848
57,137
57,13757,84854,51354,48243,04643,90941,0507,5587,5587,7515,3313,32920,25125,26521,68711,87911,8796,8138,94010,97310,9735,8354,7153,5114,4889,1465,2765,4091,189842403580580239854247
   > Total Current Liabilities 
47
42
85
239
580
580
403
842
1,189
5,409
5,276
7,563
2,544
1,261
4,715
5,835
10,973
10,973
8,940
6,813
11,879
11,879
21,537
25,165
19,951
3,029
5,331
7,751
7,558
7,558
38,867
41,911
41,200
50,546
50,785
54,505
54,177
54,17754,50550,78550,54641,20041,91138,8677,5587,5587,7515,3313,02919,95125,16521,53711,87911,8796,8138,94010,97310,9735,8354,7151,2612,5447,5635,2765,4091,189842403580580239854247
       Short-term Debt 
0
0
0
0
0
0
0
0
0
998
715
1,583
1,944
2,250
2,750
3,256
7,903
7,903
6,790
4,472
8,139
8,139
16,350
20,420
14,660
300
0
0
0
873
30,443
36,527
34,791
45,564
44,417
46,564
45,765
45,76546,56444,41745,56434,79136,52730,44387300030014,66020,42016,3508,1398,1394,4726,7907,9037,9033,2562,7502,2501,9441,583715998000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
998
715
1,583
1,944
2,250
2,750
3,256
7,903
8,251
6,790
4,472
8,139
20,663
16,350
20,420
14,660
0
0
0
0
0
29,500
35,500
33,650
44,300
42,990
44,990
44,200
44,20044,99042,99044,30033,65035,50029,5000000014,66020,42016,35020,6638,1394,4726,7908,2517,9033,2562,7502,2501,9441,583715998000000000
       Accounts payable 
15
0
0
239
165
165
216
610
949
934
1,652
992
864
768
1,297
1,638
3,070
1,739
1,427
1,800
2,353
2,353
3,646
3,207
2,966
1,896
3,766
6,080
3,299
3,299
4,492
2,454
2,704
1,258
1,162
2,165
1,786
1,7862,1651,1621,2582,7042,4544,4923,2993,2996,0803,7661,8962,9663,2073,6462,3532,3531,8001,4271,7393,0701,6381,2977688649921,6529349496102161651652390015
       Other Current Liabilities 
32
42
85
239
415
415
187
232
240
4,474
3,624
6,571
1,679
493
668
940
223
1,331
722
541
223
1,387
1,541
1,538
54
1,133
1,565
1,671
25
4,259
3,932
2,930
3,705
3,724
260
291
6,626
6,6262912603,7243,7052,9303,9324,259251,6711,5651,133541,5381,5411,3872235417221,3312239406684931,6796,5713,6244,474240232187415415239854232
   > Long-term Liabilities 
0
0
0
0
0
165
216
610
949
934
1,652
1,583
1,944
2,250
4,048
4,894
0
9,642
8,217
6,272
0
10,492
150
100
300
300
3,766
6,080
0
3,299
2,183
1,998
1,846
3,936
3,728
3,343
2,960
2,9603,3433,7283,9361,8461,9982,1833,29906,0803,76630030010015010,49206,2728,2179,64204,8944,0482,2501,9441,5831,65293494961021616500000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
1,583
1,944
2,250
0
0
0
0
0
0
0
0
150
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000100150000000002,2501,9441,58300000000000
       Deferred Long Term Liability 
0
0
0
0
438
0
0
0
111
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000001110004380000
> Total Stockholder Equity
795
748
488
1,571
634
634
2,749
1,144
-319
-4,314
-5,050
-5,913
-2,848
248
6,594
3,654
-2,315
-2,315
-1,536
-1,886
-3,824
-3,824
-11,320
-12,898
1,896
50,286
42,951
34,870
61,666
61,666
21,978
8,948
-9,681
-22,057
-31,512
-43,259
-53,831
-53,831-43,259-31,512-22,057-9,6818,94821,97861,66661,66634,87042,95150,2861,896-12,898-11,320-3,824-3,824-1,886-1,536-2,315-2,3153,6546,594248-2,848-5,913-5,050-4,314-3191,1442,7496346341,571488748795
   Common Stock
11
4
11
12
12
12
13
13
13
13
13
13
15
18
27
27
27
27
34
37
40
40
48
50
64
81
83
84
86
86
87
92
95
101
109
120
9
912010910195928786868483816450484040373427272727181513131313131312121211411
   Retained Earnings Total Equity00-260,783-246,1720-207,638-181,442-138,9100-121,625-109,325-97,778-88,275-79,461-73,908-68,259-53,7150-44,251-40,592-36,993-30,096-26,525-21,460-17,908-18,273-12,962-11,972-7,702-5,991-4,063-2,74800000
   Accumulated Other Comprehensive Income -9-2,916,000-2,841,000000000-2,352-2,499-2,587-2,537-2,463-2,393-2,2960-2,228-2,162-2,032-21-1,967-1,707-1,707-1,033-190-226-1,094-4-2-1000000
   Capital Surplus 
0
0
0
0
0
2,673
6,799
7,122
7,369
7,644
7,898
12,157
14,012
19,983
31,385
31,757
32,619
33,026
40,519
43,252
47,554
50,896
60,147
64,050
87,570
145,396
149,694
154,059
0
198,071
201,327
214,278
0
221,247
226,321
0
0
00226,321221,2470214,278201,327198,0710154,059149,694145,39687,57064,05060,14750,89647,55443,25240,51933,02632,61931,75731,38519,98314,01212,1577,8987,6447,3697,1226,7992,67300000
   Treasury Stock00000-408-548-51200000000000000000000000000000
   Other Stockholders Equity 
0
1,165
1,258
2,879
0
2,673
6,799
7,122
7,369
7,644
7,898
12,347
15,045
21,690
33,092
33,724
0
34,651
42,680
45,480
0
49,850
62,540
66,513
90,107
147,983
152,193
156,411
0
198,071
200,779
213,870
215,698
221,247
3,067,321
3,148,234
237,609
237,6093,148,2343,067,321221,247215,698213,870200,779198,0710156,411152,193147,98390,10766,51362,54049,850045,48042,68034,651033,72433,09221,69015,04512,3477,8987,6447,3697,1226,7992,67302,8791,2581,1650



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,452
Cost of Revenue-9,352
Gross Profit-6,900-6,900
 
Operating Income (+$)
Gross Profit-6,900
Operating Expense-61,895
Operating Income-68,795-68,795
 
Operating Expense (+$)
Research Development14,276
Selling General Administrative30,947
Selling And Marketing Expenses17,583
Operating Expense61,89562,806
 
Net Interest Income (+$)
Interest Income505
Interest Expense-589
Other Finance Cost-364
Net Interest Income-448
 
Pretax Income (+$)
Operating Income-68,795
Net Interest Income-448
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-79,263-58,327
EBIT - interestExpense = -69,384
-13,057,175
-63,586
Interest Expense589
Earnings Before Interest and Taxes (EBIT)-68,795-78,674
Earnings Before Interest and Taxes (EBITDA)-65,863
 
After tax Income (+$)
Income Before Tax-79,263
Tax Provision-0
Net Income From Continuing Ops-86,427-79,263
Net Income-64,175
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses71,247
Total Other Income/Expenses Net-10,468448
 

Technical Analysis of Pavmed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pavmed. The general trend of Pavmed is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pavmed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PAVmed Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.84 < 3.5 < 4.44.

The bearish price targets are: 1.8537 > 1.82 > 1.6.

Tweet this
PAVmed Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PAVmed Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PAVmed Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PAVmed Inc. The current macd is -0.10447303.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pavmed price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pavmed. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pavmed price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
PAVmed Inc Daily Moving Average Convergence/Divergence (MACD) ChartPAVmed Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PAVmed Inc. The current adx is 13.32.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pavmed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
PAVmed Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PAVmed Inc. The current sar is 2.50009025.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
PAVmed Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PAVmed Inc. The current rsi is 41.57. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
PAVmed Inc Daily Relative Strength Index (RSI) ChartPAVmed Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PAVmed Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pavmed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
PAVmed Inc Daily Stochastic Oscillator ChartPAVmed Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PAVmed Inc. The current cci is -107.70595794.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
PAVmed Inc Daily Commodity Channel Index (CCI) ChartPAVmed Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PAVmed Inc. The current cmo is -24.31226121.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
PAVmed Inc Daily Chande Momentum Oscillator (CMO) ChartPAVmed Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PAVmed Inc. The current willr is -91.93548387.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
PAVmed Inc Daily Williams %R ChartPAVmed Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PAVmed Inc.

PAVmed Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PAVmed Inc. The current atr is 0.22803744.

PAVmed Inc Daily Average True Range (ATR) ChartPAVmed Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PAVmed Inc. The current obv is -1,218,400.

PAVmed Inc Daily On-Balance Volume (OBV) ChartPAVmed Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PAVmed Inc. The current mfi is 34.44.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
PAVmed Inc Daily Money Flow Index (MFI) ChartPAVmed Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PAVmed Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

PAVmed Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PAVmed Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.568
Ma 20Greater thanMa 502.099
Ma 50Greater thanMa 1002.182
Ma 100Greater thanMa 2002.776
OpenGreater thanClose1.960
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pavmed with someone you think should read this too:
  • Are you bullish or bearish on Pavmed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pavmed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PAVmed Inc

I send you an email if I find something interesting about PAVmed Inc.


Comments

How you think about this?

Leave a comment

Stay informed about PAVmed Inc.

Receive notifications about PAVmed Inc in your mailbox!